The Latest Breaking News from diabetes

Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has been shown in the SELECT Trial to be effective in preventing the loss of kidney function in people who are overweight or obese and have established cardiovascular disease but do not have diabetes. Read further on Dynamite News:

New research verifies the intuitive: That standing is better than sitting, exercise is great for overall health and getting good sleep is imperative.

How to stop ‘the silent killer’ before even more young people are diagnosed.

Diagnoses up 39% in six years, with condition fuelled by obesity, health inequalities and junk food, study finds

A growing number of grocery-store foods, from fruit-flavored yogurts to packaged bread, are being tied to health concerns

Experts at DTechCon 2024 warn of uncontrolled diabetes due to injection errors, advocate for technology solutions for better glucose control.

JSS AHER conducted a national workshop on Type-1 Diabetes Management and Nutrition with renowned healthcare professionals.

The wellness project claims to help users make ‘smarter food choices’ based on ‘world-leading science’. But many scientists claim its fee-based services are no better than generic advice

Researchers say their findings strengthen the case for identifying people with type 2 diabetes at the earliest opportunity.